Pharmacologic activity, safety, and preliminary efficacy of GEN3009,…
A new antibody designed to fight B-cell lymphoma shows promise in early trials, with immune-response markers predicting which patients benefit most.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Comparison of epcoritamab, lenalidomide, and rituximab versus usual…
Epcoritamab combined with lenalidomide and rituximab outperforms standard chemotherapy approaches for multiply relapsed follicular lymphoma without requiring traditional chemotherapy.
Standard additionPrognostic RNA-splicing archetypes in breast cancer identified by…
AI analysis of routine breast cancer biopsies identifies splicing patterns linked to poor outcomes, potentially enabling early detection without extra molecular tests.
Novel or significantly improved treatmentAssociation between Intravenous Ketamine Treatment and Cognitive…
Intravenous ketamine for treatment-resistant depression shows no significant cognitive harm in a rigorous trial, supporting its safety profile in clinical practice.
Standard additionTemporal changes in cortisol secretion and their association with…
Long-term cortisol changes in common adrenal tumors now have clear links to heart and metabolic health outcomes, guiding personalized follow-up strategies.